THE ACUTE AND SUBACUTE TOXICITIES AND PHARMACOLOGICAL ACTIONS OF GAMI SSANGHWA TANG PREPARATIONS.

Title	THE ACUTE AND SUBACUTE TOXICITIES AND PHARMACOLOGICAL ACTIONS OF GAMI SSANGHWA TANG PREPARATIONS.
Authors	SHIN,KH: LEE,EB: CHUNG,MS: KIM,OJ: YOON,KY:
Year	1990
Volume	21
Issue	2

Paeonia species (PAEONIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
2	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
3	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
4	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
5	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
6	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
7	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
13	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
14	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
15	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
16	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
17	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
18	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
19	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
20	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
21	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
22	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
23	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
24	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
25	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
26	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
27	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
28	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
29	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
30	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
31	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
32	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE

Angelica gigas (APIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
2	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
3	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
4	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
5	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
6	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
7	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
13	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
14	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
15	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
16	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
17	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
18	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
19	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
20	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
21	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
22	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
23	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
24	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
25	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
26	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
27	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
28	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
29	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
30	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
31	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
32	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE

Astragalus membranaceus (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
2	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
3	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
4	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
5	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
6	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
7	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
13	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
14	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
15	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
16	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
17	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
18	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
19	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
20	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
21	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
22	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
23	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
24	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
25	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
26	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
27	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
28	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
29	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
30	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
31	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
32	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE

Cnidium officinale (APIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
2	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
3	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
4	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
5	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
6	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
7	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
13	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
14	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
15	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
16	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
17	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
18	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
19	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
20	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
21	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
22	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
23	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
24	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
25	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
26	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
27	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
28	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
29	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
30	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
31	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
32	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE

Glycyrrhiza glabra (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
2	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
3	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
4	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
5	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
6	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
7	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
13	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
14	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
15	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
16	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
17	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
18	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
19	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
20	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
21	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
22	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
23	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
24	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
25	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
26	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
27	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
28	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
29	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
30	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
31	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
32	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE

Rehmannia glutinosa (SCROPHULARIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
2	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
3	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
4	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
5	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
6	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
7	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
13	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
14	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
15	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
16	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
17	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
18	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
19	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
20	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
21	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
22	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
23	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
24	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
25	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
26	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
27	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
28	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
29	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
30	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
31	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
32	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE

Atractylodes species (ASTERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
2	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
3	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
4	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
5	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
6	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
7	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
13	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
14	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
15	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
16	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
17	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
18	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
19	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
20	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
21	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
22	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
23	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
24	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
25	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
26	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
27	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
28	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
29	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
30	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
31	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
32	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE

Pueraria species (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
2	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
3	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
4	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
5	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
6	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
7	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
13	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
14	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
15	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
16	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
17	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
18	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
19	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
20	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
21	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
22	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
23	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
24	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
25	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
26	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
27	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
28	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
29	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
30	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
31	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
32	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE

Cinnamomum cassia (LAURACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
2	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
3	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
4	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
5	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
6	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
7	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
13	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
14	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
15	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
16	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
17	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
18	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
19	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
20	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
21	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
22	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
23	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
24	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
25	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
26	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
27	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
28	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
29	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
30	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
31	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
32	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE

Zingiber officinale (ZINGIBERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
2	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
3	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
4	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
5	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
6	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
7	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
13	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
14	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
15	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
16	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
17	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
18	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
19	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
20	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
21	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
22	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
23	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
24	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
25	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
26	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
27	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
28	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
29	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
30	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
31	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
32	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE

Ziziphus vulgaris (RHAMNACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
2	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
3	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
4	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
5	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
6	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
7	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
13	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
14	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
15	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
16	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
17	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
18	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
19	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
20	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
21	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
22	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
23	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
24	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
25	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
26	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
27	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
28	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
29	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
30	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
31	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
32	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE

Panax ginseng (ARALIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
2	TOXICITY ASSESSMENT(QUANTITATIVE)	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	.
3	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
4	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
5	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
6	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
7	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
8	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
9	DNA DISRUPTION EFFECT	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
12	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
13	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
14	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
15	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
16	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
17	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
18	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
19	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
20	HYPOGLYCEMIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
21	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
22	PROTEIN SYNTHESIS INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
23	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
24	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
25	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
26	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
27	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
28	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
29	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
30	BARBITURATE POTENTIATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
31	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
32	ANTIFATIGUE ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE

Citation 36858

Citation Details

Summary

Organisms and Their Experiments (12)

Paeonia species (PAEONIACEAE)

Angelica gigas (APIACEAE)

Astragalus membranaceus (FABACEAE)

Cnidium officinale (APIACEAE)

Glycyrrhiza glabra (FABACEAE)

Rehmannia glutinosa (SCROPHULARIACEAE)

Atractylodes species (ASTERACEAE)

Pueraria species (FABACEAE)

Cinnamomum cassia (LAURACEAE)

Zingiber officinale (ZINGIBERACEAE)

Ziziphus vulgaris (RHAMNACEAE)

Panax ginseng (ARALIACEAE)

Show SPARQL Queries (1)

Query 1